ReviewClinical reviews in allergy & immunology2026
Clinical Factors Associated with Genetically Confirmed Inborn Errors of Immunity in Children Presenting with Immune Dysregulation.
Review in Clinical reviews in allergy & immunology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundInborn errors of immunity (IEI) are increasingly recognized as important underlying causes of immune dysregulation in children. While recurrent infections remain a classical hallmark of IEI, non-infectious manifestations such as autoimmunity, lymphoproliferation, and autoinflammation are often the dominant or presenting features, posing diagnostic challenges.
objectiveTo identify clinical features associated with IEI in children presenting with manifestations of immune dysregulation.
methodsWe conducted a multicenter retrospective–prospective cohort study including 106 children with manifestations of immune dysregulation evaluated at tertiary centers. Patients were stratified according to the presence or absence of genetically confirmed IEI.
resultsThe group with genetically confirmed IEI comprised 67 patients, whereas the group with immune dysregulation without confirmed IEI comprised 39 patients. Several clinical features were significantly associated with genetic confirmation of IEI, including multilineage cytopenia (OR 6.27, 95% CI 1.74–22.59), Evans syndrome (OR 8.29, 95% CI 1.03–66.47), and lymphoproliferation (OR 4.20, 95% CI 1.55–11.35). Combined immune dysregulation phenotypes, such as autoimmunity with lymphoproliferation (OR 2.88, 95% CI 1.05–7.86) and autoimmunity with infections (OR 2.82, 95% CI 1.24–6.38), were also associated with genetic confirmation of IEI. Among genetically confirmed cases, disorders of immune dysregulation represented the largest subgroup (37.3%), followed by predominantly antibody deficiencies (31.3%) and syndromic or combined immunodeficiencies (16.4%).
conclusionsSpecific patterns of immune dysregulation, particularly multilineage cytopenias, Evans syndrome, lymphoproliferation, and combined autoimmune phenotypes, were associated with genetically confirmed IEI in this cohort. Recognition of these clinical features may support earlier consideration of underlying IEI and help refine diagnostic decision-making in children presenting with immune dysregulation.
Indexed as
Identifiers
41862652What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.